Progress in diagnosing and treating thyroid squamous cell carcinoma under the 5th edition of WHO classification

W Ding, X Gao, X Ran - Frontiers in Endocrinology, 2024 - frontiersin.org
Squamous cell carcinoma of the thyroid (SCCT) is a rare thyroid gland malignancy, with only
a few hundred cases reported in the literature, mostly as case reports or small sample …

Primary squamous cell carcinoma of the pancreas with effective comprehensive treatment: A case report and literature review

G Zhang, Z Cheng, G Xu, X Jiang, X Wang, Q Wang - Medicine, 2018 - journals.lww.com
Interventions: She received chemoradiation along with targeted therapy and was provided
with treatment response evaluation through PET/CT. Outcomes: She eventually died of …

Prognostic characteristics of primary squamous cell carcinoma of the thyroid: a national cancer database analysis

J Limberg, TM Ullmann, D Stefanova, BM Finnerty… - World Journal of …, 2020 - Springer
Background Primary squamous cell carcinoma of the thyroid (ThySCC) is a rare cancer,
primarily described only in case reports. We aimed to characterize the prognosis of ThySCC …

Transcription factor prospero homeobox 1 (PROX1) as a potential angiogenic regulator of follicular thyroid cancer dissemination

M Rudzińska, M Mikula, KD Arczewska… - International Journal of …, 2019 - mdpi.com
It is well known that Prospero homeobox 1 (PROX1) is a crucial regulator of
lymphangiogenesis, that reprograms blood endothelial cells to lymphatic phenotype …

[HTML][HTML] Identification of potential BRAF inhibitor joint therapy targets in PTC based on WGCAN and DCGA

YL Han, XQ Yu, YZ Yin, Z Lv, CY Jia, Y Liao… - Journal of …, 2021 - ncbi.nlm.nih.gov
As the most common mutation in papillary thyroid cancer (PTC), B-type Raf kinase V600E
mutation (BRAF V600E) has become an important target for the clinical treatment of PTC …

[HTML][HTML] Treatment optimization and prognostic considerations for primary squamous cell carcinoma of the thyroid

W Wang, Q Ouyang, C Meng, L Jing, X Li - Gland Surgery, 2019 - ncbi.nlm.nih.gov
Background Primary squamous cell carcinoma of the thyroid (PSCCT) is a rare aggressive
malignancy that usually presents in an advanced stage and has a poor prognosis. Our study …

[HTML][HTML] Analysis of primary and secondary squamous cell carcinoma of the thyroid gland: a retrospective study

G Liu, X Xu, G Chen, Z Liu - Gland Surgery, 2021 - ncbi.nlm.nih.gov
Background Squamous cell carcinoma of the thyroid (SCCT) is a kind of rare malignant
disease. This study aimed to analyse the clinical characteristics of patients with primary …

The impact of transcription factor prospero homeobox 1 on the regulation of thyroid cancer malignancy

M Rudzińska, B Czarnocka - International Journal of Molecular Sciences, 2020 - mdpi.com
Transcription factor Prospero homeobox 1 (PROX1) is continuously expressed in the
lymphatic endothelial cells, playing an essential role in their differentiation. Many reports …

[PDF][PDF] RETRACTED: miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression

H Cheng, H Dong, J Feng, H Tian… - OncoTargets and …, 2018 - Taylor & Francis
Cheng H, Dong H, Feng J, Tian H, Zhang H, Xu L. Onco Targets Ther. 2018; 11: 4711–4721.
At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract …

[HTML][HTML] Agrin is a novel oncogenic protein in thyroid cancer

A Adamiok-Ostrowska, M Grzanka… - Oncology …, 2023 - spandidos-publications.com
Agrin (AGRN) is a matricellular glycoprotein involved in extracellular signal transduction.
AGRN is involved in tumorigenesis and cancer progression; however, the role of AGRN in …